OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Webinar on Cancer Biomarker
Cancer Biomarker Webinar

OriGene TissueScan in recent publications
Role of MYC-Regulated Long Noncoding RNAs in Cell Cycle Regulation and Tumorigenesis J. Natl. Cancer Inst. Apr 2015 [Tissues]

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

DNA (5 µg); Colon; Within normal limits

Specifications Related Products Research Agreement FAQs
Catalog No. Description Price Shipping
CD564782 DNA (5 µg); Colon; Within normal limits $ 209 3 days
<< Back to Search Result   Add to Shopping Cart
Disease StateNormal
Diagnosis CategoryNormal
TissueColon
Case IDCU0000011746
PrepE
Vial IDDN00000889
Frozen Sample IDFR00035218
Tissue of OriginColon
Site of FindingColon: rectosigmoid
AppearanceNormal
Sample Diagnosis (from Pathology Verification)Within normal limits
Normal100%
Lesional0%
Tumor0%
Tumor Hypo/Acellular Stroma0%
Tumor Hypercellular Stroma0%
Necrosis0%
Pathology Verification notes from H&E reviewNon Tumor Structures: 20% Mucosa, 10% Submucosa, 70% Muscle
Bioanalyzer Ratio (28S/18S)1.95
CASE Diagnosis (from medical center path report)Adenocarcinoma of colon
Age85
GenderMale
Race
Tumor GradeNot applicable
Minimum Stage GroupingNot applicable
T (Extent of Primary Tumor)Not applicable
N (Lymph node metastasis)Not applicable
M (Distant metastasis)Not applicable
Diagnostic Test Results

 

pattern
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title